Get the Stockscreener App
3.75
0.00%
0.00
After Hours:
3.75
Sophia Genetics Sa stock is traded at $3.75, with a volume of 32,491.
It is up +0.00% in the last 24 hours and up +13.98% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$3.75
Open:
$3.5
24h Volume:
32,491
Relative Volume:
0.69
Market Cap:
$248.28M
Revenue:
$62.37M
Net Income/Loss:
$-78.98M
P/E Ratio:
-3.0738
EPS:
-1.22
Net Cash Flow:
$-57.80M
1W Performance:
+5.34%
1M Performance:
+13.98%
6M Performance:
-25.00%
1Y Performance:
-7.86%
1-Day Range:
$3.50
$3.85
1-Week Range:
$3.37
$3.93
52-Week Range:
$2.70
$7.37
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer - StockTitan
SOPHiA GENETICS Reports Third Quarter 2024 Results - PR Newswire
3 Reasons Not to Give Up on Roku Stock - MSN
Vanguard Dethrones BlackRock As Second Largest ETF Manager: Here's How Their Funds With Exposure To S&P 500 Fared This Year - MSN
Cofle S.p.A. Enhances Share Buyback Strategy - MSN
Adma Biologics (ADMA) Soars 18.8%: Is Further Upside Left in the Stock? - MSN
Palantir, Trump Media Buzz Amid Investors Ahead Of Election Day - MSN
SOS Limited announces ADS ratio change - MSN
Exploring Sophia Genetics's Earnings Expectations - Benzinga
Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.16% - MSN
IPO Roundup: Heritage Distilling, Transten Global and more - MSN
SOPHiA GENETICS SA (SOPH): A Bull Case Theory - Insider Monkey
Sophia Genetics SA (SOPH) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Estimating at-risk couple rates across 1000 exome sequencing data cohort for 176 genes and its importance relevance for health policies - Nature.com
Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? - Yahoo Finance
Morgan Stanley Downgrades Biogen (BIIB) - MSN
The biggest U.S. homebuilder misses on earnings as it says buyers are staying on the sidelines - MSN
SOPHiA GENETICS (SOPH) to Release Quarterly Earnings on Tuesday - MarketBeat
US Penny Stocks To Watch In October 2024 - Simply Wall St
SOPHiA GENETICS and Hitachi Announce Collaboration to Advance Data Driven Precision Medicine - AsiaOne
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024 - Marketscreener.com
Millennium Management LLC Purchases 9,199 Shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) - Defense World
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Down 22.8% in September - MarketBeat
SOPHiA GENETICS SA (NASDAQ:SOPH) Shares Sold by Millennium Management LLC - MarketBeat
Artificial Intelligence (AI) in Precision Medicine Global Market Size, Trends 2024-2033 - WhaTech
The UAE Cerebrospinal Fluid Drainage Catheter Market Size & Outlook, 2030 - Grand View Research
Dynamic Advisor Solutions LLC Acquires 1,432 Shares of PepsiCo, Inc. (NASDAQ:PEP) - Defense World
Artificial Intelligence in Diagnostics Market to hit USD 7.3 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
What to Expect From Labcorp Holdings' Q3 2024 Earnings Report - MSN
SOPHiA GENETICS' SWOT analysis: data-driven medicine firm faces headwinds - Investing.com
Artificial Intelligence In Cancer Diagnostics Market Size, Industry Analysis, Key Insights And Forecast To ... - WhaTech
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Down 52.0% in September - Defense World
Federated Hermes Inc. Has $346,000 Stake in Photronics, Inc. (NASDAQ:PLAB) - Defense World
Global Precision medicine software Market Expected to Reach $ 3112.52 Million by 2032, Growing at 11.4% CAGR - 대구포스트
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) & Cyclo Therapeutics (NASDAQ:CYTH) - Defense World
The Agenda Setter: SOPHIE’s posthumous new album cements a pop visionary’s legacy - Dork Magazine
Sosandar – AGM Due On Thursday For Women’s Fashion Group Now Recovering Into Profits, Shares Now 10p, Brokers Predict 31p - UK Investor Magazine
Sophie's life was saved by a stranger. Some in her position have an 'unfair' disadvantage - SBS News
No luck for McDonald after another concussion setback - Albany Advertiser
‘My first impression was this person’s a genius’: the life and legacy of producer pioneer Sophie - The Guardian
Tracklist of SOPHIE's Posthumous Album Revealed - EDM.com
‘Extra proud’: Lions rookie reflects on AFLW rise - Sunshine Coast Daily
SOPHiA Presents Multimodal AI-Driven Research on Patient Stratification in Lung Cancer - Inside Precision Medicine
Tracklist Unveiled For Posthumous SOPHIE Album - Stereoboard
Sofia Connelly’s vintage store Pecorina is a love letter to Italy, in Australia - Fashion Journal
Nuvalent announces pricing of $500M upsized stock offering - MSN
SOPHiA GENETICS presents ground-breaking multimodal research on AI-driven patient stratification at ESMO 2024 - EurekAlert
SOPHiA GENETICS Unveils AI Patient Research at ESMO 2024 - Mirage News
SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024 - StockTitan
SOPHiA GENETICS announces poster presentations at ESMO 2024 - EurekAlert
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.66%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):